Power Law company profile

Lunit

Biotech & Life Sciences · Seoul, South Korea · Founded 2013 · IPO 2022 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1.16B

Market cap · Apr/2026

Revenue

$70M

Latest reported FY

Investors

17 investors on Lunit's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 1 investor entered at this stage

Kakao Ventures

Series A 3 investors entered at this stage

Formation 8

Mirae Asset Venture Investment

SBVA

Series B+ 13 investors entered at this stage

Casdin Capital

Korea Advanced Institute of Science and Technology

Shinhan Investment Corporation

Tybourne Capital Management

Global footprint

Where Lunit has talent and traffic

AI talent share

1.4% of workforce is AI talent
(5 of 355 staff)

Core AI30.85%

Other AI20.56%

Non-AI workforce35098.59%

Web traffic by country

41K monthly visits
across markets

🏳️ Korea23.2%

🏳️ Republic of20.2%

🇺🇸 United States19.8%

🇮🇳 India6.6%

🇦🇺 Australia4.9%

Top 5 markets shown

See Lunit on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo